Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 03/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 01/03/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.13% | +9.97% | +55.80% | +160.09% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +55.96% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.06% | 448B | |
| +0.99% | +4.85% | +28.17% | +23.89% | 332B | |
| +1.82% | +8.19% | +40.04% | +27.95% | 293B | |
| +0.22% | +6.75% | +31.30% | +42.34% | 286B | |
| +0.73% | +8.53% | -27.33% | -39.55% | 215B | |
| +1.56% | +6.14% | +29.30% | +60.97% | 193B | |
| +3.26% | +3.33% | +15.55% | +68.24% | 159B | |
| Average | +2.66% | +8.00% | +30.99% | +54.55% | 401.79B | |
| Weighted average by Cap. | +3.85% | +8.93% | +41.75% | +80.17% |
